Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 11: Hazardous Drugs
Author(s): Allen Loyd V Jr, Okeke Claudia C
Issue: Jan/Feb 2009 - Compounding for Pediatrics
View All Articles in Issue
Page(s): 56-62
Download in electronic PDF format for $65
Abstract: Total patient care necessitates the use of hazardous drugs in the compounding of preparations. With approximately 5.5 million U.S. healthcare workers potentially being exposed to hazardous drugs, the importance and necessity of a pharmacy establishing and maintaining standard operating procedures pertaining to the handling of hazardous drugs cannot be minimized. This article defines hazardous drugs, discusses many of the factors that impact worker exposure, identifies many of the sources of exposure, identifies the four general goals for handling hazardous drugs, discusses the proper handling and disposal of hazardous drug waste materials, and provides a checklist that can be used by a pharmacy to establish protocols for a hazardous drug program.
Related Keywords:
Claudia C. Okeke, PhD, RPh, United States Pharmacopeia, Chapter <797>, sterile preparations, hazardous drug compounding, USP, pharmacy worker exposure, occupational safety, Loyd V. Allen, Jr., PhD, RPh, hazardous drug waste disposal, employees, compliance checklist
Related Categories:
LEGAL, STERILE PREPARATIONS, UNITED STATES PHARMACOPEIA CONVENTIONS, PROFESSIONAL ISSUES, HAZARDOUS DRUGS
Printer-Friendly Version
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 11: Hazardous Drugs
Allen Loyd V Jr, Okeke Claudia C
|
Jan/Feb 2009
Pg. 56-62
|
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>,<797>, and <825>: Part 1
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 92
|
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Dillon L R
|
Jan/Feb 2020
Pg. 30-36
|
Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels
Allen Loyd V Jr, Okeke Claudia C
|
Sep/Oct 2007
Pg. 404-410
|
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>, <797>, and <825>: Part 2
Allen Loyd V Jr
|
May/Jun 2020
Pg. 180
|
Update on the Proposed Revision Process for United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations
Okeke Claudia C
|
Jul/Aug 2007
Pg. 302-305
|
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations
Ashe Krystina, Baskett Dustin
|
Sep/Oct 2018
Pg. 387-398
|
PreScription: Permissible Exposure Limits and United States Pharmacopeia Chapter <800>
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 356
|
Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 491-496
|
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
|
Nov/Dec 2003
Pg. 449-450
|